When we compared PanCK+ tumor areas between STAS (containing TN_EP and AS_EP) and NSTAS (containing TN_EP) patients, the result revealed a significant decline in the expression of the HLA-DRB5 gene in the STAS group. This evidence concerns the gene HLA-DRB5 and neoplasm.